Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020

SELL
$0.23 - $0.3 $12,933 - $16,869
-56,231 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$0.27 - $0.35 $1,350 - $1,750
5,000 Added 9.76%
56,231 $17,000
Q1 2019

May 13, 2019

BUY
$0.35 - $0.5 $901 - $1,288
2,577 Added 5.3%
51,231 $25,000
Q4 2018

Feb 13, 2019

BUY
$0.36 - $0.65 $11,215 - $20,250
31,154 Added 178.02%
48,654 $18,000
Q3 2018

Nov 13, 2018

BUY
$0.5 - $0.72 $2,500 - $3,600
5,000 Added 40.0%
17,500 $9,000
Q2 2018

Aug 13, 2018

BUY
$0.6 - $0.75 $7,500 - $9,375
12,500 New
12,500 $8,000

About PURE BIOSCIENCE, INC.


  • Ticker PURE
  • Exchange OTC
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 88,023,104
  • Market Cap $8.8M
  • Description
  • PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual prot...
More about PURE
Track This Portfolio

Track Maryland Capital Management Portfolio

Follow Maryland Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Management with notifications on news.